查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
鼻窦炎治疗的全球市场:现状分析、预测 (2022年～2028年)
市场调查报告书
商品编码
1241362

鼻窦炎治疗的全球市场:现状分析、预测 (2022年～2028年)

Global Sinusitis Treatment Market: Current Analysis and Forecast (2022-2028)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 135 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

鼻窦炎治疗的需求高涨，起因于鼻窦炎的盛行率全球增加。还有新药的R&D投资持续增加也成为市场显着成长的要素。再加上诊断药的需求高涨，市场规模在预测期间内，预计以5％的年复合成长率成长。

本报告提供全球鼻窦炎治疗的市场调查，市场定义和概要，市场成长的各种影响因素分析，市场规模的变化、预测，各种区分、各地区/主要国家的明细，法律制度，供需趋势，竞争环境，主要企业简介等彙整资讯。

目录

第1章 简介

第2章 调查手法、前提条件

第3章 市场概要

第4章 摘要整理

第5章 COVID-19:对鼻窦炎治疗市场的影响

第6章 鼻窦炎治疗市场:收益的变化、预测

第7章 市场洞察:各疾病

  • 急性鼻窦炎
  • 亚急性鼻窦炎
  • 慢性鼻窦炎

第8章 市场洞察:各治疗法

  • 止痛药
  • 抗组织胺药物
  • 皮质类固醇
  • 抗生素
  • 手术

第9章 市场洞察:各地区

  • 北美
  • 欧洲
  • 亚太地区
  • 其他地区

第10章 鼻窦炎治疗市场:市场动态

  • 推动市场要素
  • 市场课题
  • 影响分析

第11章 鼻窦炎治疗市场:市场机会

第12章 鼻窦炎治疗市场:市场趋势

第13章 需求侧、供给侧的分析

第14章 价值链分析

第15章 竞争模式

第16章 企业概要

  • Olympus Corporation
  • Medtronic
  • Stryker
  • Cipla Inc.
  • Dr. Reddy's Laboratories Ltd
  • Sanofi
  • Aurobindo Pharma
  • Intersect ENT, Inc.
  • Smith+Nephew
  • Novartis AG

第17章 免责声明

简介目录
Product Code: UMME211679

Sinusitis is a medical condition that causes inflammation along the sinus lining, which can cause symptoms like facial pain, sinus headaches, breathing problems, fatigue, tooth pain, and a loss of taste and smell. The growing demand for sinus treatment can be attributed to the increasing prevalence of rhinosinusitis across the globe. For instance, according to the World Allergy Organization 2021, the worldwide prevalence of chronic rhinosinusitis (CRS) ranges from about 8% in China, 8.4% in Korea, 11% in Europe, and 12% in the United States. Furthermore, the increasing investments in the research and development of novel medicines also attributes to the significant growth of the market.

The increasing demand for diagnostics is expected to drive the global sinusitis treatment market at a CAGR of 5%, during the forecast period. Factors such as rapid technological advancement and integration of information technology in healthcare are important factors responsible for the market growth of the sinusitis treatment market.

Based on the disease, the market has been categorized into acute sinusitis, sub-acute sinusitis, and chronic sinusitis. Among them, the chronic sinusitis segment holds a considerable share of the market. The rising incidences of chronic sinusitis along with the rise in air pollution are the important factors contributing to the share of the chronic sinusitis segment. For instance, according to the National Institute of Allergy and Infectious Diseases (NIAID), an estimated 134 million Indians suffer from chronic sinusitis.

Based on the treatment, the market has been categorized into analgesics, antihistamines, corticosteroids, antibiotics, and surgery. Among them, the antibiotics segment holds a considerable share of the market. The increasing prevalence of high effectiveness of the antibodies against them attributes to the significant share of the antibodies in the sinusitis treatment.

For a better understanding of the market adoption of the sinusitis treatment, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America is anticipated to hold a considerable market share during the forecast period. The rising number of sinusitis cases along with the presence of a large geriatric population in the region attributes to the significant share of sinusitis treatment. For instance, according to the University of Michigan Health Michigan Medicines, Chronic sinusitis affects 31 million people in the U.S. and accounts for more than 16 million outpatient visits a year.

Some of the major players operating in the market are Olympus Corporation; Medtronic; Stryker; Cipla Inc.; Dr. Reddy's Laboratories Ltd; Sanofi; Aurobindo Pharma; Intersect ENT, Inc.; Smith+Nephew; and Novartis AG

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Sinusitis Treatment Market
  • 2.2. Research Methodology of the Sinusitis Treatment Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE SINUSITIS TREATMENT MARKET

6 SINUSITIS TREATMENT MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY DISEASE

  • 7.1. Acute Sinusitis
  • 7.2. Sub-acute Sinusitis
  • 7.3. Chronic Sinusitis

8 MARKET INSIGHTS BY TREATMENT

  • 8.1. Analgesics
  • 8.2. Antihistamines
  • 8.3. Corticosteroids
  • 8.4. Antibiotics
  • 8.5. Surgery

9 MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10 SINUSITIS TREATMENT MARKET DYNAMICS

  • 10.1. Market Drivers
  • 10.2. Market Challenges
  • 10.3. Impact Analysis

11 SINUSITIS TREATMENT MARKET OPPORTUNITIES

12 SINUSITIS TREATMENT MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 13.1. Demand Side Analysis
  • 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

  • 15.1. Competitive Landscape
    • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

  • 16.1. Olympus Corporation
  • 16.2. Medtronic
  • 16.3. Stryker
  • 16.4. Cipla Inc.
  • 16.5. Dr. Reddy's Laboratories Ltd
  • 16.6. Sanofi
  • 16.7. Aurobindo Pharma
  • 16.8. Intersect ENT, Inc.
  • 16.9. Smith+Nephew
  • 16.10. Novartis AG

17 DISCLAIMER